Application 020943
- Type
- NDA
- Sponsor
- RECRO GAINESVILLE
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | VERELAN PM | VERAPAMIL HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | 100MG | Yes | No |
| 002 | VERELAN PM | VERAPAMIL HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | 200MG | Yes | No |
| 003 | VERELAN PM | VERAPAMIL HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | 300MG | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N020943-001 | VERELAN PM | VERAPAMIL HYDROCHLORIDE | 100MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 1998-11-25 | |
| N020943-002 | VERELAN PM | VERAPAMIL HYDROCHLORIDE | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 1998-11-25 | |
| N020943-003 | VERELAN PM | VERAPAMIL HYDROCHLORIDE | 300MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD, RS | 1998-11-25 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N020943-001 | VERELAN PM | 100MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 1998-11-25 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N020943-002 | VERELAN PM | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 1998-11-25 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N020943-003 | VERELAN PM | 300MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD, RS | 1998-11-25 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020943-001 | VERELAN PM | 100MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 1998-11-25 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020943-002 | VERELAN PM | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 1998-11-25 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020943-003 | VERELAN PM | 300MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD, RS | 1998-11-25 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N020943-001 | VERELAN PM | 100MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 1998-11-25 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N020943-002 | VERELAN PM | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 1998-11-25 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N020943-003 | VERELAN PM | 300MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD, RS | 1998-11-25 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020943-001 | VERELAN PM | 100MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 1998-11-25 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020943-002 | VERELAN PM | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 1998-11-25 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020943-003 | VERELAN PM | 300MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD, RS | 1998-11-25 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020943-001 | VERELAN PM | 100MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 1998-11-25 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020943-002 | VERELAN PM | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 1998-11-25 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020943-003 | VERELAN PM | 300MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD, RS | 1998-11-25 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N020943-001 | VERELAN PM | 100MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 1998-11-25 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N020943-002 | VERELAN PM | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 1998-11-25 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N020943-003 | VERELAN PM | 300MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD, RS | 1998-11-25 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N020943-001 | VERELAN PM | 100MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 1998-11-25 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N020943-002 | VERELAN PM | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 1998-11-25 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N020943-003 | VERELAN PM | 300MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD, RS | 1998-11-25 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N020943-001 | VERELAN PM | 100MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 1998-11-25 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N020943-002 | VERELAN PM | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 1998-11-25 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N020943-003 | VERELAN PM | 300MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD, RS | 1998-11-25 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N020943-001 | VERELAN PM | 100MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 1998-11-25 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N020943-002 | VERELAN PM | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 1998-11-25 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N020943-003 | VERELAN PM | 300MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD, RS | 1998-11-25 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N020943-001 | VERELAN PM | 100MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 1998-11-25 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N020943-002 | VERELAN PM | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 1998-11-25 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N020943-003 | VERELAN PM | 300MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD, RS | 1998-11-25 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N020943-001 | VERELAN PM | 100MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 1998-11-25 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N020943-002 | VERELAN PM | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 1998-11-25 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N020943-003 | VERELAN PM | 300MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD, RS | 1998-11-25 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N020943-001 | VERELAN PM | 100MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 1998-11-25 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N020943-002 | VERELAN PM | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 1998-11-25 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N020943-003 | VERELAN PM | 300MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD, RS | 1998-11-25 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N020943-001 | VERELAN PM | 100MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 1998-11-25 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N020943-002 | VERELAN PM | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 1998-11-25 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N020943-003 | VERELAN PM | 300MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD, RS | 1998-11-25 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N020943-001 | VERELAN PM | 100MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 1998-11-25 | 8072bd15b7f6… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | N020943-001 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | N020943-002 | AB | 1 | 74a2ff9319b5… |
| 2019-09-15 20:21 UTC | 2019-09 | N020943-001 | AB | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | N020943-002 | AB | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | N020943-001 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | N020943-002 | AB | 1 | ea99ee380514… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Verapamil Hydrochloride | VERAPAMIL HYDROCHLORIDE | Chartwell RX, LLC | 18f6d349-8c5c-4443-ac65-16bf6619ecdc | 2025-03-25 | Warnings, Adverse reactions | 020943 NDA020943 |
| Verapamil Hydrochloride | VERAPAMIL HYDROCHLORIDE | Wilshire Pharmaceuticals, Inc. | 5f665d08-e1e4-422a-88c2-d8834abf9e1a | 2024-11-27 | Warnings, Adverse reactions | 020943 NDA020943 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 62175-485 | Verapamil Hydrochloride | Verapamil Hydrochloride | Lannett Company, Inc. | NDA | Current |
| 62175-485 | Verapamil Hydrochloride | Verapamil Hydrochloride | Lannett Company, Inc. | NDA | Current |
| 62175-485 | Verapamil Hydrochloride | Verapamil Hydrochloride | Lannett Company, Inc. | NDA | Current |
| 62175-485 | Verapamil Hydrochloride | Verapamil Hydrochloride | Lannett Company, Inc. | NDA | Current |
| 62175-485 | Verapamil Hydrochloride | Verapamil Hydrochloride | Kremers Urban Pharmaceuticals Inc. | NDA | Current |
| 62175-486 | Verapamil Hydrochloride | Verapamil Hydrochloride | Lannett Company, Inc. | NDA | Current |
| 62175-486 | Verapamil Hydrochloride | Verapamil Hydrochloride | Lannett Company, Inc. | NDA | Current |
| 62175-486 | Verapamil Hydrochloride | Verapamil Hydrochloride | Lannett Company, Inc. | NDA | Current |
| 62175-486 | Verapamil Hydrochloride | Verapamil Hydrochloride | Lannett Company, Inc. | NDA | Current |
| 62175-486 | Verapamil Hydrochloride | Verapamil Hydrochloride | Kremers Urban Pharmaceuticals Inc. | NDA | Current |
| 62175-487 | Verapamil Hydrochloride | Verapamil Hydrochloride | Lannett Company, Inc. | NDA | Current |
| 62175-487 | Verapamil Hydrochloride | Verapamil Hydrochloride | Lannett Company, Inc. | NDA | Current |
| 62175-487 | Verapamil Hydrochloride | Verapamil Hydrochloride | Lannett Company, Inc. | NDA | Current |
| 62175-487 | Verapamil Hydrochloride | Verapamil Hydrochloride | Lannett Company, Inc. | NDA | Current |
| 62175-487 | Verapamil Hydrochloride | Verapamil Hydrochloride | Kremers Urban Pharmaceuticals Inc. | NDA | Current |
| 62175-570 | VERELAN PM | verapamil hydrochloride | Lannett Company, Inc. | NDA | Current |
| 62175-570 | VERELAN PM | verapamil hydrochloride | Kremers Urban Pharmaceuticals Inc. | NDA | Current |
| 62175-570 | VERELAN PM | verapamil hydrochloride | Lannett Company, Inc. | NDA | Current |
| 62175-570 | VERELAN PM | verapamil hydrochloride | Lannett Company, Inc. | NDA | Current |
| 62175-570 | VERELAN PM | verapamil hydrochloride | Lannett Company, Inc. | NDA | Current |
| 62175-571 | VERELAN PM | verapamil hydrochloride | Lannett Company, Inc. | NDA | Current |
| 62175-571 | VERELAN PM | verapamil hydrochloride | Kremers Urban Pharmaceuticals Inc. | NDA | Current |
| 62175-571 | VERELAN PM | verapamil hydrochloride | Lannett Company, Inc. | NDA | Current |
| 62175-571 | VERELAN PM | verapamil hydrochloride | Lannett Company, Inc. | NDA | Current |
| 62175-571 | VERELAN PM | verapamil hydrochloride | Lannett Company, Inc. | NDA | Current |
| 62175-572 | VERELAN PM | verapamil hydrochloride | Lannett Company, Inc. | NDA | Current |
| 62175-572 | VERELAN PM | verapamil hydrochloride | Kremers Urban Pharmaceuticals Inc. | NDA | Current |
| 62175-572 | VERELAN PM | verapamil hydrochloride | Lannett Company, Inc. | NDA | Current |
| 62175-572 | VERELAN PM | verapamil hydrochloride | Lannett Company, Inc. | NDA | Current |
| 62175-572 | VERELAN PM | verapamil hydrochloride | Lannett Company, Inc. | NDA | Current |
| 63629-7233 | Verapamil Hydrochloride | Verapamil Hydrochloride | Bryant Ranch Prepack | NDA | Current |
| 63629-7233 | Verapamil Hydrochloride | Verapamil Hydrochloride | Bryant Ranch Prepack | NDA | Current |
| 63629-8017 | Verapamil Hydrochloride | Verapamil Hydrochloride | Bryant Ranch Prepack | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 60230 | SUPPL | 2019-10-04 |
| 60225 | SUPPL | 2019-10-04 |
| 45916 | SUPPL | 2016-11-22 |
| 45938 | SUPPL | 2016-11-21 |
| 35690 | SUPPL | 2014-10-15 |
| 3817 | SUPPL | 2014-10-14 |
| 26264 | SUPPL | 2011-11-16 |
| 13792 | SUPPL | 2011-11-14 |
| 35688 | SUPPL | 2010-04-30 |
| 3815 | SUPPL | 2010-04-09 |
| 26263 | SUPPL | 2010-04-05 |
| 35689 | SUPPL | 2010-04-04 |
| 26262 | SUPPL | 2009-12-24 |
| 13791 | SUPPL | 2009-12-17 |
| 3816 | SUPPL | 2007-05-07 |
| 26261 | SUPPL | 2004-05-07 |
| 13790 | SUPPL | 2004-05-07 |
| 35687 | ORIG | 1998-11-25 |
| 26260 | ORIG | 1998-11-25 |
| 21294 | ORIG | 1998-11-25 |